Milestone Pharmaceuticals's three largest insider shareholders as of July 26, 2026 are Joseph Oliveto (President And Ceo, 446.24K shares), Lorenz Muller (Chief Commercial Officer, 205.41K shares), David Bharucha (Chief Medical Officer, 113.18K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Paul F Truex | - | 81,780 | 0 | 01 Jun, 2022 |
| Joseph Oliveto | President And Ceo | 446,244 | 0 | 20 Apr, 2026 |
| Michael John Tomsicek | - | 15,000 | 0 | 21 Oct, 2022 |
| Robert James Wills | - | 65,000 | 0 | 15 Jul, 2025 |
| Lorenz Muller | Chief Commercial Officer | 205,406 | 0 | 28 Jan, 2026 |
| Debra K. Liebert | - | 16,793 | 0 | 15 Jul, 2025 |
| Amit Hasija | Cfo Evp Of Corp. Development | 99,848 | 0 | 28 Jan, 2026 |
| Richard C Pasternak | - | 10,000 | 0 | 21 Oct, 2022 |
| David Bharucha | Chief Medical Officer | 113,181 | 0 | 28 Jan, 2026 |
| Jeffrey Edward Nelson | Chief Operating Officer | 49,848 | 0 | 28 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Apr, 2026 | Joseph Oliveto | Common Shares | D | 36,500 | $2.26 | 446,244 | D | S |
| 16 Apr, 2026 | Joseph Oliveto | Common Shares | D | 36,500 | $2.26 | 446,244 | D | S |
| 16 Apr, 2026 | Joseph Oliveto | Common Shares | D | 36,500 | $2.26 | 446,244 | D | S |
| 02 Feb, 2026 | Jeffrey Edward Nelson | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Lorenz Muller | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Lorenz Muller | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Jeffrey Edward Nelson | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Joseph Oliveto | Employee Stock Option (right to buy) | A | 679,000 | $0.00 | 679,000 | D | A |
| 02 Feb, 2026 | Lorenz Muller | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Lorenz Muller | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Jeffrey Edward Nelson | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Joseph Oliveto | Employee Stock Option (right to buy) | A | 679,000 | $0.00 | 679,000 | D | A |
| 02 Feb, 2026 | Jeffrey Edward Nelson | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Amit Hasija | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Joseph Oliveto | Employee Stock Option (right to buy) | A | 679,000 | $0.00 | 679,000 | D | A |
| 02 Feb, 2026 | Joseph Oliveto | Employee Stock Option (right to buy) | A | 679,000 | $0.00 | 679,000 | D | A |
| 02 Feb, 2026 | David Bharucha | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Lorenz Muller | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Jeffrey Edward Nelson | Employee Stock Option (right to buy) | A | 204,000 | $0.00 | 204,000 | D | A |
| 02 Feb, 2026 | Joseph Oliveto | Employee Stock Option (right to buy) | A | 679,000 | $0.00 | 679,000 | D | A |